ClinicalTrials.gg
Drug

Trifluridine clinical trials

studies test it
9
open now
4
in phase 3
2
first study started
2013

How each study uses Trifluridine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Trifluridine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Apr 1980 · VIROPTIC · NDA 018299 (FDA, Drugs@FDA)
European Union
25 Apr 2016 · Lonsurf · EMEA/H/C/003897 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Trifluridine
3

Studies by the year they started

7 studies that test it; most in 2025 (5)

Studies that test Trifluridine, by start year
YearStudies
20131
20161
20255

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
4
Phase 3
2
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 6

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1) · Taiho Oncology, Inc. (1) · Institut de Recherches Internationales Servier (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Amgen (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Sun Yat-sen University (1) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1)

Often tested with

Tested in the same studies.

Tipiracil (6) · HMPL-013 (2) · Bemarituzumab (1) · Paclitaxel (1) · Ramucirumab (1) · Irinotecan (1) · Trifluridine tipiracil drug combination (1) · Bevacizumab (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Trifluridine.

Studies

Open first, then newest update. How each study uses Trifluridine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 9

Given beside what is tested · 4 — Trifluridine is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Trifluridine

Codes

What other systems call Trifluridine · ClinicalTrials.gg INT008356

  • MeSH (NLM) D014271TrifluridineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) RMW9V5RW38TRIFLURIDINEConfirmed FDA, NLM, Wikidata
  • RxNorm 10803Confirmed FDA, Wikidata
  • Wikidata Q2359590trifluridineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C905TrifluridineOne source FDA
  • DrugBank DB00432One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.